Status:
UNKNOWN
Effects of Virtual Reality on Rehabilitation in Patients With Heart Failure
Lead Sponsor:
Valentina Micheluzzi
Conditions:
Heart Failure
Reduced Ejection Fraction
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Background. To improve symptoms and reduce poor outcomes related to heart failure (HF), international guidelines recommend cardiac rehabilitation (CR), particularly for those with a reduced ejection f...
Eligibility Criteria
Inclusion
- age over 18 years;
- clinically stable chronic HF diagnosis with left ventricular ejection fraction (LVEF) \< 40%
Exclusion
- conditions that exclude exercise training (e.g., bone fractures);
- conditions that exclude VR use of VR (e.g., blindness and deafness
- severe cognitive impairment, documented with a score of 0 - 4 on the Six-item Screener;
- end-stage renal disease requiring dialysis;
- ascertained advanced pneumopathies;
- active neoplasms;
- rheumatic diseases.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06115928
Start Date
December 1 2023
End Date
November 30 2024
Last Update
November 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Valentina Micheluzzi
Sassari, Italy, 07100